Fractyl Health Sharpens Focus on Revita Following Positive Pivotal Results, Advancing Toward Planned FDA De Novo Submission in Post-GLP-1 Weight Maintenance

Stock Information for Fractyl Health, Inc.

Loading

Please wait while we load your information from QuoteMedia.